Recombinant multi-species DLK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DLK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a transmembrane protein that contains multiple epidermal growth factor repeats that functions as a regulator of cell growth. The encoded protein is involved in the differentiation of several cell types including adipocytes. This gene is located in a region of chromosome 14 frequently showing unparental disomy, and is imprinted and expressed from the paternal allele. A single nucleotide variant in this gene is associated with child and adolescent obesity and shows polar overdominance, where heterozygotes carrying an active paternal allele express the phenotype, while mutant homozygotes are normal. [provided by RefSeq, Nov 2015]
The Alternative Names of target: DLK,DLK-1,DLK1,Delta1,Dlk1,DlkI,FA1,Ly107,PREF1,Peg9,Pref-1,Protein delta homolog 1,SCP1,ZOG,Zog,pG2,pref-1
Go
to DLK1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0084-Ag-1/ GM-Tg-hg-IP0084-Ag-2 | Human DLK1 protein | Human |
| GM-Tg-rg-IP0084-Ag-1/ GM-Tg-rg-IP0084-Ag-2 | Rat DLK1 protein | Rat |
| GM-Tg-mg-IP0084-Ag-1/ GM-Tg-mg-IP0084-Ag-2 | Mouse DLK1 protein | Mouse |
| GM-Tg-cynog-IP0084-Ag-1/ GM-Tg-cynog-IP0084-Ag-2 | Cynomolgus/Rhesus macaque DLK1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0084-Ag-1/ GM-Tg-felg-IP0084-Ag-2 | Feline DLK1 protein | Feline |
| GM-Tg-cang-IP0084-Ag-1/ GM-Tg-cang-IP0084-Ag-2 | Canine DLK1 protein | Canine |
| GM-Tg-bovg-IP0084-Ag-1/ GM-Tg-bovg-IP0084-Ag-2 | Bovine DLK1 protein | Bovine |
| GM-Tg-equg-IP0084-Ag-1/ GM-Tg-equg-IP0084-Ag-2 | Equine DLK1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0084-Ag-1/ GM-Tg-hg-IP0084-Ag-2;
GM-Tg-rg-IP0084-Ag-1/ GM-Tg-rg-IP0084-Ag-2;
GM-Tg-mg-IP0084-Ag-1/ GM-Tg-mg-IP0084-Ag-2; GM-Tg-cynog-IP0084-Ag-1/ GM-Tg-cynog-IP0084-Ag-2; GM-Tg-felg-IP0084-Ag-1/ GM-Tg-felg-IP0084-Ag-2; GM-Tg-cang-IP0084-Ag-1/ GM-Tg-cang-IP0084-Ag-2; GM-Tg-bovg-IP0084-Ag-1/ GM-Tg-bovg-IP0084-Ag-2; GM-Tg-equg-IP0084-Ag-1/ GM-Tg-equg-IP0084-Ag-2 |
| Products Name | DLK1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | DLK1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DLK1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.